Additional file 1 of Invasive pulmonary aspergillosis among ICU patients with COVID-19, influenza, and preexisting host factors: a nationwide cohort study

Résumé fourni par la source

Supplementary Material 1: Additional file 1: Table S1 Coding for the case definition of preexisting host factors. Table S2 Types and codes of antifungal agents. Table S3 Comorbidities based on the Charlson Comorbidity Index. Table S4 ICD-10-based classification of organ dysfunction. Table S5 Baseline characteristics of intensive care unit patients in the unmatched cohort. Table S6 Baseline characteristics of high-risk subgroup in the matched cohort. Table S7 Primary and secondary outcomes of high-risk subgroup. Table S8 Risk factors for invasive pulmonary aspergillosis in the high-risk subgroup. Table S9 Primary and secondary outcomes according to steroid dose and duration. Table S10 Risk factors for COVID-19-associated pulmonary aspergillosis. Table S11 Incidence of CAPA according to the vaccination status and study period

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.